EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis
Language English Country Germany Media print-electronic
Document type Journal Article, Meta-Analysis, Review, Systematic Review
PubMed
28849432
DOI
10.1007/s00296-017-3800-8
PII: 10.1007/s00296-017-3800-8
Knihovny.cz E-resources
- Keywords
- Central and Eastern Europe, EQ-5D, Health-related quality of life, Meta-analysis, Musculoskeletal diseases, Patient reported outcomes,
- MeSH
- Chronic Pain psychology therapy MeSH
- Quality of Life * MeSH
- Quality-Adjusted Life Years * MeSH
- Qualitative Research MeSH
- Humans MeSH
- Musculoskeletal Diseases psychology therapy MeSH
- Connective Tissue Diseases psychology therapy MeSH
- Prospective Studies MeSH
- Cross-Sectional Studies MeSH
- Randomized Controlled Trials as Topic MeSH
- Retrospective Studies MeSH
- Health Status MeSH
- Health Surveys MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Review MeSH
- Systematic Review MeSH
- Geographicals
- Europe MeSH
EQ-5D is becoming the preferred instrument to measure health-state utilities involved in health technology assessment. The objective of this study is to assess the state of EQ-5D research in musculoskeletal disorders in 8 Central and Eastern European countries and to provide a meta-analysis of EQ-5D index scores. Original research articles published in any language between Jan 2000 and Sept 2016 were included, if they reported any EQ-5D outcome from at least two musculoskeletal patients from Austria, Bulgaria, the Czech Republic, Hungary, Poland, Romania, Slovakia, or Slovenia. Risk of bias was assessed with the Cochrane Collaboration's tool. Twenty-nine articles (5992 patients) were included on rheumatoid arthritis (n = 7), osteoporosis (n = 5), chronic pain (n = 5), osteoarthritis (n = 4), ankylosing spondylitis (n = 2), psoriatic arthritis (n = 2), total hip replacement (n = 2), and scleroderma (n = 2). Low back pain was under-represented, while studies in neck pain, systemic lupus erythematosus, gout, and childhood disorders were lacking. EQ-5D index scores were reported in 24 studies, while the version of the instrument and the value-set was not specified in 41% and 46% of the articles, respectively. Meta-analysis was performed on 24 disease states involving 6876 observation points. Intervention effect was reported in 22 subgroups, out of which risk of bias was low in 41%. This review provides recommendations to improve reporting standards of EQ-5D results and highlights potential areas for future research. Coordinated research in conditions with greatest public health impact as well as a development of a regional value-set could provide locally relevant health-state utilities that are transferable among countries within the region.
Department of Health Economics Corvinus University of Budapest Fővám tér 8 1093 Budapest Hungary
Department of Rheumatology Flór Ferenc County Hospital Semmelweis tér 1 2143 Kistarcsa Hungary
Institute for Economic Research Kardeljeva ploščad 17 1000 Ljubljana Slovenia
Institute of Rheumatology Na Slupi 4 Prague 128 00 Czech Republic
Sandoz Hungária Kft Bartók Béla u 43 47 1134 Budapest Hungary
See more in PubMed
Clin Rheumatol. 2013 Oct;32(10):1451-8 PubMed
Lancet. 2015 Nov 28;386(10009):2145-91 PubMed
Clin Rheumatol. 2012 Oct;31(10):1437-42 PubMed
Eur J Phys Rehabil Med. 2014 Aug;50(4):373-81 PubMed
J Rheumatol. 2011 Aug;38(8):1770-5 PubMed
Arthritis Res Ther. 2016 Feb 19;18:51 PubMed
J Rheumatol. 2003 May;30(5):941-7 PubMed
Health Policy. 1996 Jul;37(1):53-72 PubMed
Lancet. 2006 Sep 9;368(9539):917-8 PubMed
Osteoporos Int. 2013 Mar;24(3):811-23 PubMed
Pharmacoeconomics. 2008;26(11):925-35 PubMed
Arthritis Care Res (Hoboken). 2012 Jun;64(6):826-32 PubMed
J Rheumatol. 2008 Apr;35(4):662-7 PubMed
Value Health. 2014 Nov;17(7):A378 PubMed
Value Health. 2010 Mar-Apr;13(2):289-97 PubMed
Rheumatol Int. 2013 Jul;33(7):1813-9 PubMed
Rheumatology (Oxford). 2011 Jan;50(1):196-203 PubMed
Int J Biometeorol. 2016 Nov;60(11):1675-1680 PubMed
Qual Life Res. 2011 Dec;20(10 ):1727-36 PubMed
Control Clin Trials. 1986 Sep;7(3):177-88 PubMed
Eur J Health Econ. 2016 Apr;17 Suppl 1:79-87 PubMed
Expert Rev Pharmacoecon Outcomes Res. 2017 Apr;17 (2):203-211 PubMed
Rheumatol Int. 2012 Apr;32(4):963-9 PubMed
Reumatologia. 2015;53(6):301-8 PubMed
BMJ. 2009 Jul 21;339:b2535 PubMed
Qual Life Res. 2016 Nov;25(11):2693-2710 PubMed
Orv Hetil. 2014 Nov 30;155(48):1913-21 PubMed
Eur J Health Econ. 2014 May;15 Suppl 1:S13-25 PubMed
Rheumatol Int. 2012 Oct;32(10):3163-9 PubMed
Pharmacoeconomics. 2009;27(9):767-79 PubMed
Patient Relat Outcome Meas. 2015 Jul 07;6:167-77 PubMed
Rheumatol Int. 2009 Dec;30(2):199-205 PubMed
Health Policy. 1990 Dec;16(3):199-208 PubMed
Med Care. 1997 Nov;35(11):1095-108 PubMed
J Korean Med Sci. 2008 Oct;23(5):852-6 PubMed
J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1398-405 PubMed
Br J Rheumatol. 1997 May;36(5):551-9 PubMed
J Rheumatol. 2014 Jun;41(6):1067-76 PubMed
Neuro Endocrinol Lett. 2015;36(3):231-5 PubMed
Rheumatology (Oxford). 2010 Oct;49(10):1920-8 PubMed
PLoS One. 2015 Mar 17;10(3):e0119683 PubMed
Eur J Health Econ. 2014 May;15 Suppl 1:S73-82 PubMed
Scand J Rheumatol. 2010 Aug;39(4):303-9 PubMed
J Rheumatol. 2008 Apr;35(4):592-602 PubMed
Joint Bone Spine. 2010 Dec;77 Suppl 2:S107-12 PubMed
J Clin Nurs. 2012 Oct;21(19-20):2843-50 PubMed
Eur J Health Econ. 2014 May;15 Suppl 1:S65-71 PubMed
Rheumatol Int. 2013 Oct;33(10):2569-76 PubMed
Health Econ. 2010 Aug;19(8):886-905 PubMed
Orv Hetil. 2008 Apr 20;149(16):733-41 PubMed
Eur J Health Econ. 2014 May;15 Suppl 1:S83-92 PubMed
Semin Arthritis Rheum. 2014 Oct;44(2):123-30 PubMed
Clin Rheumatol. 2015 Jun;34(6):1097-108 PubMed
Eur J Health Econ. 2014 May;15 Suppl 1:S1-4 PubMed
Orv Hetil. 2003 Mar 2;144(9):423-7 PubMed
BMC Musculoskelet Disord. 2014 Jan 20;15:26 PubMed